Prevalence, awareness, and determinants of type 2 diabetes mellitus among commercial taxi drivers in buffalo city metropolitan municipality South Africa: A cross-sectional survey

Medicine
Aanuoluwa Odunayo AdedokunAnthony I Ajayi

Abstract

Undiagnosed type 2 diabetes mellitus constitutes a significant threat to the health of commercial taxi drivers, safety of the passengers and other road users. This study determines the prevalence of pre-diabetes and type 2 diabetes mellitus among commercial taxi drivers in Buffalo City Metropolitan Municipality (BCMM), Eastern Cape and examines the factors associated with type 2 diabetes mellitus.A cross-sectional survey of 403 commercial taxi drivers was undertaken using the World Health Organization (WHO) STEPwise approach. Anthropometric, blood pressure, and blood glucose measurements followed standard procedure. Diabetes status was determined using the fasting blood glucose (FBG) test. Diabetes was defined as a FBG ≥7.0mmol/L or self-reported history of diabetes or current diabetes medication use (treatment), while pre-diabetes was defined as a FBG of 5.6 to 6.9 mmol/L. Awareness of diabetes was defined as a self-reported history of diabetes.The mean age of the study participants was 43.3 ± 12.5years. Prevalence of pre-diabetes and diabetes were 17% (95% CI: 13.4-20.6) and 16% (95% CI: 12.4-19.6), respectively. Of those who had diabetes (n = 63), the majority were aware of their diabetes status (n = 43) and were on treatmen...Continue Reading

References

Jan 1, 1997·Occupational Medicine·G C Jones, B M Frier
Jun 25, 1999·Family Practice·W J de GrauwC van Weel
Feb 11, 2005·Clinical and Experimental Hypertension : CHE·Lewis Landsberg, Mark Molitch
Mar 3, 2007·American Journal of Public Health·Lenny R VartanianKelly D Brownell
Apr 30, 2009·Diabetes Care·Francesca AmatiBret H Goodpaster
Aug 5, 2010·International Journal of Occupational Medicine and Environmental Health·Andrzej Marcinkiewicz, Dorota Szosland
Jul 19, 2011·Aging·Uma Gunasekaran, Maureen Gannon
Jan 28, 2012·Current Atherosclerosis Reports·Bernard M Y Cheung, Chao Li
Jun 16, 2012·TheScientificWorldJournal·Raquel Pastréllo HirataLuis Vicente Franco de Oliveira
Oct 27, 2012·Diabetes Care·M Sue KirkmanCarrie S Swift
Jan 4, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Jun 4, 2013·Journal of Diabetes and Metabolic Disorders·Nazanin IzadiMaryam Saraei
Jun 15, 2013·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F B Hu
Nov 26, 2013·Progress in Cardiovascular Diseases·Fasil Tekola-AyeleCharles N Rotimi
Jan 28, 2014·BMC Medicine·Aaron LeongKaberi Dasgupta
Mar 8, 2014·BMJ Open·Abd Moain Abu DabrhMohammad Hassan Murad
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw
Jun 20, 2014·Indian Journal of Endocrinology and Metabolism·Geoff Gill
Jan 30, 2015·Cardiovascular Journal of Africa·UNKNOWN Hypertension guideline working groupY Veriava
Feb 25, 2015·Journal of Occupational and Environmental Medicine·Matthew S ThieseKurt T Hegmann
Mar 11, 2017·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·V Pillay-van WykD Bradshaw

❮ Previous
Next ❯

Software Mentioned

Creative Research Systems
Statistical Package for Social Science ( SPSS )

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.